The event served as a platform to discuss advances in nuclear medicine, emphasizing its role in precise diagnosis and targeted cancer therapy, with discussions on PET/CT and SPECT/CT imaging, modern radiotracers, theranostic treatments, and metabolic response assessment.

The conference highlighted cutting-edge imaging technologies (PET/CT, SPECT/CT), modern radiotracers, theranostic treatments, metabolic response assessment, and integrating nuclear medicine within comprehensive oncology treatment pathways to improve early detection and targeted therapy for cancer and other diseases.

The scientific program blended theoretical and practical elements, emphasizing real-life clinical cases to help practitioners review evidence-based practices and apply them in clinical settings.

Dr. Firuz Ibrahim, Interim Head of Nuclear Medicine at Burjeel Medical City and Organizing Committee Chair, noted rapid advancements in nuclear medicine that enable precise, personalized patient care while reducing unnecessary interventions and enhancing safety and effectiveness.

The conference drew more than 300 specialists from the UAE and international locations across multiple disciplines related to nuclear medicine, including surgery, medical oncology, gastroenterology, urology, endocrinology, neurology, radiation oncology, hematology, bone marrow, and orthopedics.

The Advances in Nuclear Medicine: Precision Imaging and Therapy 2026 conference was officially launched in Abu Dhabi by Burjeel Cancer Institute, underscoring Abu Dhabi’s role as a hub for advanced medical events and cancer care.

Key speakers and organizers stated that hosting such events supports scientific research, better clinical decision-making, improved patient outcomes, and aligns with Abu Dhabi’s goal to be a regional and global center of excellence in cancer care.

Leaders from Burjeel Cancer Institute, including Professor Humaid bin Harmal Al Shamsi and Dr. Ibrahim Abu Gheida, described the event as part of ongoing efforts to promote continuous medical education, multidisciplinary collaboration, and medical innovation in Abu Dhabi.

Nuclear medicine was highlighted for enabling early disease detection and effective treatment across cancer, cardiovascular diseases, endocrine disorders, and other conditions.